Detailed Information
Cited 2 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Multicenter phase Ib/II study of second-line trastuzumab, ramucirumab, and paclitaxel in patients with HER2-positive advanced gastric or gastroesophageal junction cancer: Updated HER-RAM study with biomarker analysis
- Authors
- Rha, SY[Rha, Sun Young]; Kim, CG[Kim, Chang Gon]; Jung, M[Jung, Minkyu]; Kim, HS[Kim, Hyo Song]; Lee, CK[Lee, Choong-kun]; Jeung, HC[Jeung, Hei-Cheul]; Koo, DH[Koo, Dong-Hoe]; Bae, WK[Bae, Woo Kyun]; Zang, DY[Zang, Dae Young]; Kim, H[Kim, Hyunki]; Chung, HCC[Chung, Hyun Cheol Cheol]
- Issue Date
- 1-Feb-2022
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.40, no.4
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 40
- Number
- 4
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.